3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Moles and melanoma risk similar worldwide

CancerFeb 13, 09

Although where one lives may influence the risk for skin cancer, people with a large number of moles seem to have a consistent risk regardless of their latitude of residence, researchers have found.

Moles, also known as melanocytic nevi, are a precursor of melanoma, a deadly form of skin cancer.

“We carried out a study in collaboration with groups around the world to further understand the risk for melanoma that is associated with having large number of nevi,” Dr. Julia A. Newton-Bishop told Reuters Health.

Newton-Bishop of the University of Leeds, UK and colleagues pooled data from 15 studies involving 5,421 people with melanoma and 6,966 controls without melanoma.

They found that people with the highest number of moles on their body had a greatly increased risk for melanoma compared with those with the lowest number of moles, regardless of where they lived.

Overall, “the study showed that the risk associated with larger numbers of moles was remarkably constant between studies and at different latitudes,” Newton-Bishop explained.

“The incidence of melanoma continues to increase in many countries,” she added, concluding that “our study highlights the fact that individuals within those populations who have more moles are at greater risk, and should both avoid sunburn, and know how to recognize a melanoma.”

SOURCE: International Journal of Cancer, January 15, 2009.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site